Current and Emerging Therapies in Neuroendocrine Tumors: Impact of Genetic Targets on Clinical Outcomes

Publisher： Bentham Science Publishers

E-ISSN： 2212-6988|1|1|28-39

ISSN： 2212-697x

Source： Clinical Cancer Drugs, Vol.1, Iss.1, 2013-12, pp. : 28-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current and Emerging Therapies in Neuroendocrine Tumors: Impact of Genetic Targets on Clinical Outcomes

By  

Clinical Cancer Drugs, Vol. 1, Iss. 1, 2014-01 ,pp. : 28-39

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging therapies for the treatment of patients with advanced neuroendocrine tumors

By Chan Jennifer A   Kulke Matthew H  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. : 253-270

Informa Healthcare

Access to resources Recommend Favorite

Current Therapies and Emerging Targets for the Treatment of Diabetes

By  

Current Pharmaceutical Design, Vol. 7, Iss. 6, 2001-04 ,pp. : 417-450

Bentham Science Publishers

Access to resources Recommend Favorite

Current and emerging therapies in osteoporosis

By Buchman Alan   DeSantis Anthony  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 835-84

Informa Healthcare

Access to resources Recommend Favorite

Neuroendocrine Tumors Clinical Practice Guidelines

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 2, 2006-02 ,pp. : 102-102

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite